Minimum Inhibitory Concentration (MIC)

Minimum Inhibitory Concentration (MIC) is a quantitative microbiological parameter used to determine the lowest concentration of an antimicrobial compound capable of preventing detectable microbial growth under standardized in vitro conditions. Rather than simply indicating whether a microorganism is susceptible or resistant, MIC provides a numerical estimate of the antimicrobial concentration required to suppress multiplication. The value is generally reported in µg/mL or mg/L, depending on the antimicrobial substance and experimental protocol.

MIC is determined by exposing a standardized microbial inoculum to a series of progressively decreasing concentrations of an antimicrobial agent. After an appropriate incubation period, microbial growth is assessed using visual turbidity, optical density measurements, colorimetric indicators, fluorescence, or other validated detection methods. The first concentration at which no observable growth is detected is designated the MIC. MIC represents an experimentally defined inhibitory threshold rather than an absolute measure of microbial killing.

The interpretation of MIC depends strongly on the organism, antimicrobial compound, growth medium, inoculum density, incubation conditions, and analytical methodology. Small changes in these parameters can influence the measured value, making methodological standardization essential for meaningful comparisons. Common experimental approaches include broth microdilution, agar dilution, and related susceptibility-testing procedures. Broth microdilution is particularly useful when multiple antimicrobial concentrations and microbial isolates must be evaluated systematically.

An MIC value can also provide important information for antimicrobial susceptibility characterization. When interpreted against established clinical or experimental breakpoints, the measured concentration may help categorize an organism as susceptible, intermediate, or resistant. However, an MIC should not be interpreted independently of the relevant breakpoint system because the numerical value alone does not establish therapeutic success or failure.

MIC is distinct from the Minimum Bactericidal Concentration (MBC). While MIC identifies the lowest concentration that prevents visible growth, MBC refers to the lowest concentration associated with a defined reduction or elimination of viable microorganisms after subculture. Therefore, an antimicrobial can demonstrate growth inhibition at a concentration that does not necessarily produce microbial killing.

In antimicrobial research, MIC measurements are valuable for comparing the inhibitory potency of conventional antibiotics, novel synthetic compounds, natural products, antimicrobial peptides, nanoparticles, and combination treatments. MIC determination can also serve as an initial screening endpoint before subsequent investigations involving time-kill kinetics, post-antibiotic effects, synergistic interactions, resistance development, or mechanism-of-action studies.

MIC should be regarded as a condition-dependent experimental endpoint. A lower MIC generally indicates stronger inhibitory activity under the tested conditions, but it does not automatically imply superior clinical efficacy. Interpretation requires consideration of pharmacological exposure, toxicity, tissue penetration, microbial physiology, and experimental reproducibility.

Why Is MIC Important?

MIC is an important quantitative parameter in microbiology because it provides a measurable indication of how strongly an antimicrobial compound inhibits the growth of a particular microorganism. Rather than simply reporting whether an organism appears susceptible or resistant, MIC testing identifies the lowest concentration of an antimicrobial that prevents visible microbial growth under defined laboratory conditions. This makes MIC values particularly useful for characterizing antimicrobial activity and understanding differences in microbial responses.

MIC determination can contribute to the selection of an appropriate antimicrobial by providing concentration-based information that can be interpreted alongside established clinical or experimental susceptibility criteria. When an organism demonstrates a low MIC to a compound, the antimicrobial may exhibit greater inhibitory activity under the conditions tested. Conversely, an elevated MIC may indicate reduced susceptibility and can prompt consideration of alternative compounds or further investigation of resistance mechanisms.

MIC values are also valuable for comparing antimicrobial compounds. Researchers can evaluate whether newly developed molecules, modified formulations, or naturally derived substances exhibit meaningful inhibitory effects against target microorganisms. Such comparisons can support the identification of promising candidates during early-stage antimicrobial research and development.

In antimicrobial susceptibility testing, MIC measurements provide standardized quantitative data that can complement qualitative susceptibility categories. They are particularly useful when investigating changes in susceptibility over time, evaluating emerging resistance patterns, or characterizing the antimicrobial response of clinically or experimentally relevant isolates.

MIC should not be interpreted as a standalone measure of treatment success. Its significance depends on factors such as the microorganism, antimicrobial agent, testing methodology, pharmacokinetic and pharmacodynamic properties, and applicable interpretive breakpoints. MIC remains a fundamental laboratory parameter because it connects microbial growth inhibition with a defined antimicrobial concentration.

MIC testing provides a practical quantitative foundation for antimicrobial characterization, susceptibility assessment, compound comparison, resistance investigation, and antimicrobial development, making it an essential component of modern microbiological research.

Principle behind MIC testing

MIC testing is based on a concentration-response principle in which a microorganism is challenged with progressively higher levels of an antimicrobial compound under controlled experimental conditions. The objective is to identify the lowest antimicrobial concentration capable of preventing detectable microbial multiplication during the defined incubation period. Rather than measuring antimicrobial activity from a single exposure level, the assay establishes a concentration gradient that reveals the transition between unrestricted growth and effective growth inhibition.

In a typical MIC experiment, a standardized microbial inoculum is introduced into a series of test conditions containing increasing concentrations of the antimicrobial agent. Each concentration represents a distinct exposure environment in which the microorganism encounters a different antimicrobial pressure. At concentrations below the inhibitory threshold, cellular processes remain sufficiently active to support replication, resulting in detectable microbial growth. As antimicrobial concentration increases, cellular targets become progressively affected, and the ability of the organism to maintain normal metabolic and proliferative activity decreases.

The response is commonly evaluated by observing changes in turbidity, optical density, or another validated indicator of microbial proliferation. A visible increase in turbidity indicates that the microorganism has multiplied despite the antimicrobial exposure, whereas an absence of detectable growth suggests that the antimicrobial concentration has suppressed proliferation under the specified assay conditions. The MIC is therefore determined at the point where the observable growth response changes from positive to negative across the concentration series.

The MIC does not necessarily represent the concentration that kills the entire microbial population. It defines an inhibitory threshold for detectable growth, whereas bactericidal activity requires additional assessment, such as determination of the minimum bactericidal concentration. MIC values should be interpreted as experimental measurements that depend on the microorganism, antimicrobial compound, inoculum characteristics, incubation conditions, medium composition, exposure duration, and method used for endpoint determination.

The underlying concept can be viewed as a controlled interrogation of microbial susceptibility. Each successive antimicrobial concentration applies a greater selective pressure, allowing the investigator to locate the concentration at which measurable proliferation is no longer supported. Accurate MIC determination therefore depends not only on identifying the first concentration without visible growth but also on maintaining standardized experimental conditions throughout the concentration range. This systematic approach converts a qualitative observation of microbial inhibition into a reproducible quantitative parameter that can be used to characterize antimicrobial potency and compare susceptibility patterns.

In the broth dilution method, a standardized bacterial inoculum is exposed to progressively decreasing concentrations of an antimicrobial agent in liquid medium. Microbial growth is assessed across the concentration series, typically by visible turbidity. The MIC is defined as the lowest antimicrobial concentration that completely prevents visible growth. The transition from growth to no growth across successive concentrations provides the MIC endpoint (Figure 1).

Methods used to determine MIC

The MIC of an antimicrobial agent can be established through quantitative susceptibility-testing procedures that expose a defined microbial inoculum to a graded series of antimicrobial concentrations. The principal methods include broth dilution, agar dilution, and automated susceptibility platforms. Although these approaches differ in their experimental format and readout, each aims to identify the lowest antimicrobial concentration that prevents detectable microbial growth under standardized test conditions.

Broth dilution provides a direct and widely applicable method for MIC determination. In this approach, the antimicrobial compound is prepared in a sequence of decreasing concentrations within a liquid growth medium. A standardized microbial suspension is subsequently introduced into each concentration, followed by incubation under conditions appropriate for the organism under investigation. Following incubation, microbial growth is assessed by observing turbidity or another validated growth indicator. The MIC is assigned to the lowest antimicrobial concentration at which visible growth is absent relative to the appropriate growth control. Broth dilution is particularly useful because it generates a concentration-dependent response and permits quantitative comparison among test isolates.

Two formats of broth dilution are commonly employed. Macrobroth dilution uses relatively larger volumes of culture medium and antimicrobial preparations, making it suitable for controlled laboratory investigations where sample volume is not a major limitation. Microbroth dilution, in contrast, uses substantially smaller volumes distributed across multi-well plates. This format facilitates simultaneous testing of multiple antimicrobial concentrations and isolates while reducing reagent consumption. Microbroth dilution is therefore well suited to experiments requiring extensive concentration ranges or repeated susceptibility measurements.

Agar dilution determines MIC by incorporating defined concentrations of an antimicrobial substance directly into solidified agar media. Separate agar plates containing progressively increasing antimicrobial concentrations are inoculated with standardized microbial suspensions. After incubation, growth on each plate is evaluated and compared with the antimicrobial-free control. The MIC corresponds to the lowest concentration that completely suppresses observable colony development. This approach can accommodate multiple organisms on the same concentration-defined medium and is useful when reproducible endpoint determination across a collection of isolates is required.

Automated antimicrobial susceptibility systems provide an alternative approach in which microbial growth is monitored through instrument-based measurements. These platforms typically employ standardized panels containing predetermined antimicrobial concentrations and detect growth using optical, biochemical, or other instrument-specific signals. The resulting data are processed automatically to generate susceptibility profiles and, where applicable, MIC values. Automated testing can improve workflow efficiency, reduce manual interpretation, and support standardized processing of large numbers of clinical or experimental isolates.

Test strip-based gradient diffusion such as the Epsilometer (E) test is another practical method for estimating MIC values. In this technique, a plastic strip containing a continuous gradient of antimicrobial concentrations is placed on an agar surface previously inoculated with a standardized microbial suspension. During incubation, antimicrobial diffusion produces an elliptical zone of growth inhibition around the strip. The MIC is determined at the point where the margin of the inhibition ellipse intersects the concentration scale printed on the strip. This method provides a convenient visual endpoint and requires relatively simple laboratory handling.

Establishment of a controlled antimicrobial concentration gradient

Serial dilution provides a systematic approach for generating a defined range of antimicrobial concentrations that can be evaluated against a standardized microbial population. The central principle is to expose microorganisms to progressively decreasing quantities of an antimicrobial compound and observe the concentration at which visible growth is no longer supported. This arrangement creates a measurable concentration-response relationship and provides the experimental basis for determining the MIC of an antimicrobial agent.

The antimicrobial solution is initially prepared at a precisely defined starting concentration. From this stock solution, a sequence of dilutions is produced using an appropriate sterile diluent or growth medium. Two-fold serial dilution is commonly employed because each successive concentration represents one-half of the preceding concentration. For example, a concentration series may progress systematically from a relatively high antimicrobial level to increasingly lower levels. Maintaining an accurately calculated dilution sequence is essential because the interpretation of microbial inhibition depends directly on the concentration assigned to each test condition.

Each dilution is subsequently associated with a standardized microbial inoculum. Standardization of the inoculum reduces experimental variation by ensuring that differences in microbial growth are primarily attributable to antimicrobial concentration rather than substantial differences in the number of organisms introduced into individual test conditions. The inoculated dilution series is then maintained under controlled experimental conditions appropriate for the microorganism and antimicrobial system being investigated.

As the antimicrobial concentration decreases, its inhibitory effect may become progressively weaker. At sufficiently high concentrations, microbial multiplication may be absent or substantially suppressed. At lower concentrations, visible growth may reappear. The resulting pattern establishes a concentration gradient spanning inhibitory and non-inhibitory conditions. The MIC is identified as the lowest tested antimicrobial concentration that prevents visible microbial growth under the defined experimental conditions.

The concentration gradient therefore functions as more than a simple dilution sequence; it creates a structured experimental framework for distinguishing between concentrations that effectively restrict microbial proliferation and those that permit continued growth. Accurate preparation, consistent mixing, appropriate controls, and reliable concentration labeling are particularly important because even small preparation errors can shift the apparent inhibitory threshold.

In experimental antimicrobial studies, the dilution series can also provide a foundation for subsequent comparisons among different compounds, microbial isolates, or treatment conditions. Because each concentration represents a predefined exposure level, the resulting observations can be organized into a reproducible concentration-response profile. This approach enables antimicrobial activity to be assessed quantitatively rather than relying solely on a qualitative observation of whether microbial growth occurs. Serial dilution establishes the controlled concentration landscape required for MIC determination, linking antimicrobial exposure to measurable microbial growth behavior in a standardized experimental system.

How is the MIC determined?

The MIC is a quantitative approach that is used to identify the lowest effective antimicrobial concentration of an antimicrobial agent including antibiotics. It is determined by exposing a microorganism to a defined series of antimicrobial concentrations and then identifying the lowest concentration that prevents detectable microbial growth under standardized laboratory conditions. Unlike a simple positive-or-negative susceptibility test, MIC determination provides a quantitative measurement of antimicrobial activity and allows the response of the organism to be compared with established clinical or experimental thresholds.

The process begins with preparation of a standardized microbial inoculum. A suspension containing a controlled number of viable microorganisms is introduced into a series of test tubes or microplate wells containing progressively increasing concentrations of the antimicrobial compound. The concentration range is selected so that the test includes levels below, near, and above the expected inhibitory concentration. Appropriate growth and sterility controls are included to confirm that the assay is functioning correctly.

Following inoculation, the prepared cultures are incubated under conditions appropriate for the microorganism being investigated. Temperature, incubation duration, atmospheric conditions, inoculum density, medium composition, and antimicrobial preparation can influence the observed result. MIC measurements are meaningful only when the experimental conditions are sufficiently standardized and controlled.

After incubation, each concentration is examined for evidence of microbial multiplication. In a conventional broth-based assay, microbial proliferation may produce visible turbidity, reflecting an increase in suspended cells. A tube or well that becomes cloudy is therefore interpreted as showing detectable growth. In contrast, a comparatively clear tube or well indicates that growth has been sufficiently suppressed to remain below the visual detection threshold of the method.

The test concentrations are then arranged from the lowest to the highest antimicrobial level. The MIC is assigned to the lowest concentration at which no visible microbial growth is detected. Importantly, the MIC does not necessarily mean that every microorganism has been killed. It indicates that multiplication has been inhibited under the specific conditions of the assay. A concentration above the MIC may be required to produce a bactericidal or fungicidal effect.

Modern MIC determination can involve methods such as broth microdilution, in which antimicrobial concentrations are distributed across multiple wells of a microplate. This approach permits simultaneous evaluation of numerous concentrations and can generate a concentration-dependent growth pattern. Instead of relying exclusively on visual inspection, some laboratory systems use spectrophotometric measurements, automated optical detection, fluorescence-based approaches, or other quantitative signals to identify changes associated with microbial growth.

The resulting MIC value is subsequently interpreted in relation to an established susceptibility breakpoint, where applicable. Breakpoints are developed using microbiological, pharmacological, and clinical considerations and help classify an organism–drug combination according to categories such as susceptible or resistant. The numerical MIC should not be interpreted in isolation when the objective is clinical decision-making.

Several experimental factors can alter MIC values, including inoculum size, medium characteristics, pH, incubation conditions, antimicrobial stability, and endpoint interpretation. Rigorous quality control is consequently essential for obtaining reproducible results. In essence, MIC determination follows a straightforward principle: increase the antimicrobial concentration systematically, observe the corresponding growth response, and identify the first concentration at which detectable growth is suppressed. The resulting value provides a standardized quantitative indicator of antimicrobial inhibitory activity.

Experimental procedure for determination of MIC by two-fold serial dilution

The two-fold serial dilution technique provides a systematic concentration gradient for evaluating antimicrobial activity. Reliable MIC and MBC determination depends on accurate dilution, standardized inoculum preparation, appropriate controls, consistent incubation, and objective interpretation of microbial growth.

1. Preparation of the dilution series

• Arrange five or more sterile test tubes in a test-tube rack and label them sequentially as Tube A, Tube B, Tube C, Tube D, and Tube E, depending on the number of concentrations required. Prepare two additional tubes for the appropriate controls.

• Using a sterile pipette, dispense 0.5 mL of Mueller-Hinton (MH) broth into each of the experimental tubes (A-E). Mueller-Hinton broth is commonly used for antimicrobial susceptibility testing because its standardized composition supports reproducible evaluation of antimicrobial activity.

• Add 0.5 mL of the antimicrobial test compound prepared from the specified stock solution to Tube A and mix thoroughly to ensure uniform distribution.

• Perform the two-fold serial dilution by transferring an equal volume from Tube A into Tube B after adequate mixing. Continue the sequential transfer through Tubes C, D, and E, mixing each tube thoroughly before each transfer.

• Under the stated dilution arrangement, the nominal concentrations in Tubes A-E are 25, 12.5, 6.25, 3.125, and 1.563 mg/mL, respectively. Following the final transfer, remove and discard the specified volume from Tube E to maintain comparable working volumes.

2. Preparation and addition of the bacterial inoculum

• Prepare a fresh bacterial suspension according to the laboratory’s validated inoculum-preparation procedure.

• Standardize the bacterial suspension to the required turbidity using an appropriate reference, such as the 0.5 McFarland standard, to promote consistency in the microbial inoculum.

• Transfer the required volume of the standardized bacterial suspension into each experimental tube containing the antimicrobial dilution.

• Mix the contents of each tube carefully to ensure uniform distribution of the bacterial cells throughout the antimicrobial-containing broth.

3. Preparation of control tubes

• Prepare a growth control containing the bacterial inoculum and MH broth without the antimicrobial agent. This tube should demonstrate visible microbial growth and serves as a reference for uninhibited bacterial proliferation.

• Prepare a sterility control containing the appropriate broth and antimicrobial preparation without bacterial inoculum. This tube should remain clear and provides evidence that the medium and test materials are not contaminated.

• Include the controls in every assay because their performance is essential for valid interpretation of the experimental tubes.

4. Incubation

• Incubate the inoculated tubes according to the validated conditions specified by the laboratory’s applicable antimicrobial susceptibility-testing standard.

• Maintain the required incubation temperature, atmosphere, and duration consistently for all experimental and control tubes.

• Following incubation, allow the tubes to remain undisturbed before assessment to facilitate consistent evaluation of visible microbial growth.

5. Determination of the MIC

• Examine each tube for visible turbidity or cloudiness, which indicates microbial growth.

• Compare the experimental tubes with the growth and sterility controls before assigning an MIC value.

• The MIC is defined as the lowest tested concentration of the antimicrobial agent that prevents visible growth of the test microorganism under the specified test conditions.

• Tubes exhibiting turbidity indicate visible microbial growth, whereas a clear tube indicates inhibition of visible growth at that concentration.

• The MIC should only be reported when the control results satisfy the laboratory’s acceptance criteria. If all tested concentrations demonstrate growth, the MIC should be reported as not determined (ND) within the concentration range investigated.

6. Determination of the MBC

• The Minimum Bactericidal Concentration (MBC) is the lowest concentration of the antimicrobial agent that results in no detectable recovery of viable microorganisms following transfer to an antimicrobial-free recovery medium under the defined test conditions.

• To determine the MBC, samples from appropriate tubes showing no visible growth are subcultured onto suitable antimicrobial-free solid media using the laboratory’s validated procedure.

• Following the specified incubation period, examine the recovery plates for evidence of microbial growth.

• The lowest antimicrobial concentration from which no detectable microbial growth is recovered is recorded as the MBC.

7. Interpretation and reporting

• Record the appearance of every tube systematically, including the observed turbidity and corresponding antimicrobial concentration.

• Report the MIC together with the appropriate concentration units and identify the microorganism and relevant test conditions.

• Where applicable, report the MBC separately from the MIC because inhibition of visible growth does not necessarily demonstrate microbial killing.

• Any assay in which the controls fail to perform according to the established acceptance criteria should be considered unsuitable for interpretation and repeated in accordance with the laboratory’s quality-control procedures.

Factors that affect the MIC

The MIC is not determined solely by the antimicrobial compound. Its measured value can shift substantially with experimental and biological conditions. The microbial species and strain genotype influence susceptibility through differences in cell-envelope architecture, metabolic activity, efflux systems, and resistance determinants. Inoculum density is another important variable because a larger starting population may increase the probability of resistant subpopulations and alter antimicrobial exposure per cell.

The composition of the growth medium can modify drug activity by changing nutrient availability, ionic strength, protein binding, or pH. Similarly, incubation temperature, atmospheric conditions, and incubation duration can affect cellular growth kinetics and consequently the apparent inhibitory endpoint. The physicochemical properties of the antimicrobial, including solubility, stability, adsorption to laboratory materials, and degradation during storage or incubation, may also influence the concentration actually available to the microorganism.

Additional variation can arise from inoculum preparation, dilution accuracy, endpoint interpretation, and plate-to-plate handling. MIC determination requires tightly controlled experimental parameters and validated procedures. Standardization reduces technical variability, improves reproducibility between laboratories, and strengthens the reliability of MIC values for comparative antimicrobial susceptibility assessment.

Interpretation and applications of MIC

The MIC provides a quantitative measure of the lowest concentration of an antimicrobial agent that visibly inhibits the growth of a microorganism under defined laboratory conditions. MIC results can support antimicrobial susceptibility assessment, but their interpretation should not rely solely on the numerical value. In accordance with Clinical and Laboratory Standards Institute (CLSI) guidance, MICs should be interpreted using organism-specific and antimicrobial-specific clinical breakpoints, where established. These breakpoints allow isolates to be categorized into clinically meaningful groups such as susceptible, intermediate, or resistant, depending on the applicable standard and testing conditions.

MIC measurements can also facilitate comparisons of antimicrobial activity among compounds when experiments are performed under standardized conditions. However, an experimentally determined MIC should be distinguished from a clinical susceptibility category because the latter incorporates validated breakpoint criteria and clinical considerations. MIC testing is additionally valuable in antimicrobial discovery, particularly for evaluating novel compounds, investigating structure–activity relationships, screening microbial isolates, and monitoring changes in susceptibility. Consistent methodology, appropriate inoculum density, incubation conditions, media composition, and quality-control procedures are essential for generating reproducible results. MIC data are most informative when interpreted within a standardized framework such as CLSI methodology, rather than being treated as an isolated numerical measurement.

Key distinctions between MIC and MBC

MIC and MBC are complementary microbiological parameters that distinguish growth suppression from microbial killing. The MIC is the lowest concentration of an antimicrobial agent that prevents detectable or visible growth of a microorganism under defined laboratory conditions. It primarily reflects the concentration required to inhibit proliferation, rather than necessarily eliminate viable cells.

The MBC represents the lowest antimicrobial concentration capable of producing a substantial reduction in viable bacterial cells, typically confirmed by subculturing from concentrations showing no visible growth onto antimicrobial-free media. Lack of subsequent colony formation indicates bactericidal activity.

A central distinction is therefore functional: MIC indicates inhibition, whereas MBC provides evidence of killing. Because inhibition can occur before cellular eradication, the MBC is generally equal to or greater than the MIC. A microorganism may remain viable at its MIC despite appearing completely inhibited in the original culture.

The relationship between these measurements can provide additional insight into an antimicrobial’s activity profile. A relatively close MIC-MBC relationship may indicate effective killing near the inhibitory threshold, while a substantially higher MBC can suggest that considerably more antimicrobial exposure is required for bactericidal action. Evaluating both parameters can strengthen experimental characterization of antimicrobial performance and help distinguish growth-limiting effects from true bactericidal activity.

References

Andrews, J. M. (2001). Determination of minimum inhibitory concentrations. Journal of Antimicrobial Chemotherapy, 48 (Suppl. 1), 5–16.

Kadeřábková, N., Mahmood, A. J. S., & Mavridou, D. A. I. (2024). Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) assays. npj Antimicrobial Resistance, 2, 37.

Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021). The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens, 10(2), 165.

Rodríguez-Melcón, C., Alonso-Calleja, C., García-Fernández, C., Carballo, J., & Capita, R. (2022). Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for twelve antimicrobials (biocides and antibiotics) in eight strains of Listeria monocytogenes. Biology, 11(1), 46.

Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols, 3, 163–175.

Barenfanger J, Drakel C and Kacich (1999). Clinical and Financial Benefits of Rapid Bacterial Identification and Antimicrobial Susceptibility Testing. Journal of Clinical Microbiology, 37(5):1415-1418.

Doern G, Vautour R, Gaudet M, Levy B (1994). Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol, 32:1757–1762.

Doern G.V (1995). Susceptibility tests of fastidious bacteria. Manual of Clinical Microbiology, 6^th edition, Murray P.R, Baron E.J, Pfaller M.A, Tenover F.C, Yolken R, American Society for Microbiology, Washington DC, Pp. 1342-1349.

Livermore D.M, Winstanley T.B, Shannon K.P (2001). Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother, 48 Suppl 1:87-102.

Mahon C. R, Lehman D.C and Manuselis G (2011). Textbook of Diagnostic Microbiology. Fourth edition. Saunders Publishers, USA.

National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial susceptibility testing. 8^th Informational Supplement. M100 S12. National Committee for Clinical Laboratory Standards, 2002. Villanova, Pa.

Washington J.A (1993). Rapid antimicrobial susceptibility testing: technical and clinical considerations. Clin Microbiol Newsl, 15:153–155.